SEC Form 4 · accession 0001179110-18-008938
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stuart A Arbuckle
Director
Period of report
Jun 20, 2018
Accepted (ET)
Jun 22, 2018 · 2:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Share UnitF1,F2,F3 | $0.00 | Jun 20, 2018 | A | 4,000 | A | Sep 1, 2018 | — | Common Stock | 4,000 | 10,500 | D |
| Stock option (right to buy)F4 | $11.21 | Jun 20, 2018 | A | 18,000 | A | Sep 1, 2018 | Jun 20, 2028 | Common Stock | 18,000 | 18,000 | D |
| Deferred Share UnitF1,F2,F5 | $0.00 | Jun 20, 2018 | A | 1,500 | A | Oct 1, 2018 | — | Common Stock | 1,500 | 12,000 | D |
| Stock option (right to buy)F6 | $11.21 | Jun 20, 2018 | A | 15,800 | A | Sep 1, 2018 | Jun 20, 2028 | Common Stock | 15,800 | 15,800 | D |
Explanation of responses
- F1The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis.
- F2The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors.
- F3The deferred share units vest quarterly on 9/1/18, 12/1/18, 3/1/19, and 6/1/19, contingent upon the individual remaining a director as of each vesting date.
- F4Exercisable as to 4,500 shares on on 9/1/18, 12/1/18, 3/1/19, and 6/1/19, contingent upon the individual remaining a director as of each vesting date.
- F5The deferred share units vest as follows: 375 units on 10/1/18, and 125 units on each of Jan 1, April 1, July 1, and October 1, thereafter, beginning on January 1, 2019 and ending on January 1, 2021, contingent upon the individual remaining a director as of each vesting date.
- F6Exercisable as follows: 3,951 shares on 9/1/18, 1,317 shares each on 12/1/18, 3/1/19, 6/1/19, 9/1/19, 12/1/19 and 1,316 shares each on 3/1/2020, 6/1/2020,/1/2020 and 12/1/2020, contingent upon the individual remaining a director as of each vesting date.